6190 — PhoenixBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥2bn
- ¥946m
- ¥2bn
- 23
- 34
- 27
- 14
Annual cashflow statement for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -224 | -393 | 511 | 59.8 | -433 |
| Depreciation | |||||
| Non-Cash Items | -24.1 | 263 | 10.5 | -1.74 | 291 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 90.6 | 60 | -267 | -163 | 40.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -102 | 16.4 | 277 | -79.3 | -73 |
| Capital Expenditures | -182 | -6.77 | -12.4 | -38.8 | -32.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.46 | -0.204 | -144 | 154 | 4.33 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -185 | -6.97 | -156 | 115 | -28 |
| Financing Cash Flow Items | — | — | -0.001 | -725 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -160 | -34.7 | 86.6 | -245 | -128 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -448 | -2.31 | 230 | -170 | -236 |